Extensions

Term and Application History of US Patent 12,452,192

Based on an analysis of the patent documentation and its prosecution history, here are the details regarding the term, related applications, and family members for US Patent 12,452,192.

Patent Term Adjustments (PTA) and Extensions (PTE):

• Patent Term Adjustment (PTA): A review of the patent's file wrapper indicates that there has been no Patent Term Adjustment granted for this patent. The prosecution timeline did not trigger statutory provisions for adjustments due to USPTO delays.
• Patent Term Extension (PTE): There is no indication of any Patent Term Extension under 35 U.S.C. § 156. Such extensions are typically granted for delays caused by pre-market regulatory review by agencies like the Food and Drug Administration (FDA) and are not applicable to the technology area of this patent.

Continuation and Divisional Applications:

The application for US Patent 12,452,192 is part of a chain of continuing applications. This relationship is critical for determining the patent's expiration date, as the term is calculated from the earliest non-provisional filing date in the family.

• Application Number: 19/205,114
• Filing Date: May 12, 2025

This application is a continuation of:

• Application No. 18/981,108, filed December 13, 2024.

Which is a continuation of:

• Application No. 18/358,519, filed July 25, 2023 (now US Patent 12,184,451).

Which is a continuation of:

• Application No. 17/888,249, filed August 15, 2022 (now US Patent 11,750,419).

Which is a continuation of:

• Application No. 17/461,624, filed August 30, 2021 (now US Patent 11,418,366).

Which is a continuation of:

• Application No. 17/000,997, filed August 24, 2020 (now US Patent 11,108,595).

Which is a continuation of:

• Application No. 15/563,253, filed September 29, 2017 (now US Patent 10,756,929).

This application, in turn, is a U.S. National Stage of International Application No. PCT/US2016/026489, which was filed on April 7, 2016.

The PCT application claims priority to two U.S. provisional applications:

• U.S. Provisional Application No. 62/144,293, filed April 7, 2015.
• U.S. Provisional Application No. 62/151,174, filed April 22, 2015.

There are no divisional applications related to US Patent 12,452,192.

Patent Family Members:

The patent family for US 12,452,192 includes the parent and grandparent patents in its chain of continuity, as well as its international counterpart.

• Direct Parent: US 12,184,451
• Family Members (US):
  • US 11,750,419
  • US 11,418,366
  • US 11,108,595
  • US 10,756,929
• International Family Member (PCT Application): WO 2016/164687 A1 (published from PCT/US2016/026489)

Projected Expiration Date:

The term of a U.S. patent is generally 20 years from the filing date of the earliest U.S. non-provisional application to which it claims priority. In this case, the chain of continuity traces back to the PCT application filed on April 7, 2016.

• Earliest Effective Filing Date: April 7, 2016 (the filing date of the parent PCT application).
• Base Term: 20 years from the earliest filing date.
• PTA/PTE: 0 days.

Calculation: April 7, 2016 + 20 years = April 7, 2036.

Therefore, the projected expiration date for US Patent 12,452,192 is April 7, 2036. This date is subject to the timely payment of all required maintenance fees.